Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Daplusiran by Johnson & Johnson for Hepatitis B: Likelihood of Approval
Daplusiran is under clinical development by Johnson & Johnson and currently in Phase II for Hepatitis B. According to GlobalData,...